FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


23449 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage I American Joint Committee on Cancer stage I (qualifier value)
Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IA American Joint Committee on Cancer stage IA (qualifier value)
Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IB American Joint Committee on Cancer stage IB (qualifier value)
Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IC American Joint Committee on Cancer stage IC (qualifier value)
Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IIA American Joint Committee on Cancer stage IIA (qualifier value)
Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IIB American Joint Committee on Cancer stage IIB (qualifier value)
Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage III American Joint Committee on Cancer stage III (qualifier value)
Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IIIA American Joint Committee on Cancer stage IIIA (qualifier value)
Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IIIB American Joint Committee on Cancer stage IIIB (qualifier value)
Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IIIC American Joint Committee on Cancer stage IIIC (qualifier value)
Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IV American Joint Committee on Cancer stage IV (qualifier value)
Epithelial ovarian tumour, FIGO stage IVA American Joint Committee on Cancer stage IVA (qualifier value)
Epithelial ovarian tumour, FIGO stage IVB American Joint Committee on Cancer stage IVB (qualifier value)
Epithelial stromal corneal dystrophy Epithelial basement membrane dystrophy (disorder)
Epithelial tumor, benign, no International Classification of Diseases for Oncology subtype Benign epithelial neoplasm
Epithelioid hemangioendothelioma Epithelioid hemangioendothelioma, malignant (morphologic abnormality)
Epoetin alfa 10000unt/mL injection Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug)
Epoetin alfa 10000unt/mL injection solution 1mL vial Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug)
Epoetin alfa 10000unt/mL solution Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug)
Epoetin alfa 20000unt/mL injection solution 1mL vial Epoetin alfa 20000 unit/mL solution for injection
Epoetin alfa 2000unt/mL injection Epoetin alfa 2000 unit/mL solution for injection
Epoetin alfa 2000unt/mL injection solution 1mL vial Epoetin alfa 2000 unit/mL solution for injection
Epoetin alfa 2000unt/mL solution Epoetin alfa 2000 unit/mL solution for injection
Epoetin alfa 3000unt/mL injection solution 1mL vial Product containing precisely epoetin alfa 3000 unit/1 milliliter conventional release solution for injection (clinical drug)
Epoetin alfa 4000unt/mL injection solution 1mL vial Epoetin alfa 4000 unit/mL solution for injection
Epoetin alfa 4000unt/mL solution Epoetin alfa 4000 unit/mL solution for injection
Epoetin beta 10,000iu powder and solvent for injection solution cartridge Epoetin beta only product in parenteral dose form
Epoetin beta 10,000iu powder for conventional release solution for injection cartridge Epoetin beta only product in parenteral dose form
Epoetin beta 100,000iu powder and solvent for injection solution vial Epoetin beta only product in parenteral dose form
Epoetin beta 100,000iu powder for conventional release solution for injection vial Epoetin beta only product in parenteral dose form
Epoetin beta 20,000iu powder and solvent for injection solution cartridge Epoetin beta only product in parenteral dose form
Epoetin beta 20,000iu powder for conventional release solution for injection cartridge Epoetin beta only product in parenteral dose form
Epoetin beta 50,000iu powder and solvent for injection solution vial Epoetin beta only product in parenteral dose form
Epoetin beta 50,000iu powder for conventional release solution for injection vial Epoetin beta only product in parenteral dose form
Epoetin beta 500iu powder and solvent for injection solution vial Epoetin beta only product in parenteral dose form
Epoetin beta 60,000iu powder and solvent for injection solution cartridge Epoetin beta only product in parenteral dose form
Epoetin beta 60,000iu powder for conventional release solution for injection cartridge Epoetin beta only product in parenteral dose form
Epoophoron Wolffian body rest
Epstein syndrome MYH9-related disease (MYH9-RD) is an inherited giant platelet disorder with a complex phenotype characterized by congenital thrombocytopenia and possible subsequent manifestations of sensorineural hearing loss, presenile cataracts, elevation of liver enzymes, and/or progressive nephropathy often leading to end-stage renal disease (ESRD). Epstein syndrome, Fechtner syndrome, May-Hegglin anomaly and Sebastian syndrome, previously described as distinct disorders, represent some of the different clinical presentations of MYH9-RD.
Eptifibatide 0.75mg injection Product containing precisely eptifibatide 750 microgram/1 milliliter conventional release solution for injection (clinical drug)
Eptifibatide 0.75mg/mL injection Product containing precisely eptifibatide 750 microgram/1 milliliter conventional release solution for injection (clinical drug)
Eptifibatide 0.75mg/mL injection solution 100mL bag Product containing precisely eptifibatide 750 microgram/1 milliliter conventional release solution for injection (clinical drug)
Eptifibatide 750micrograms/mL infusion solution 100mL vial Product containing precisely eptifibatide 750 microgram/1 milliliter conventional release solution for injection (clinical drug)
Equine anti-human thymocyte immunoglobulin 20mg/mL injection solution 5mL vial Product containing precisely equine antithymocyte immunoglobulin 20 milligram/1 milliliter conventional release solution for injection (clinical drug)
Equine arteritis virus antibody Viral antibody
Equine infectious anemia virus antibody Viral antibody
Equus asinus asinus Equus asinus
Erect abdominal X-ray NOS Erect plain X-ray of abdomen (procedure)
Erect abdominal X-ray NOS Erect plain X-ray of abdomen (procedure)
Ergonovine maleate 200mcg/mL injection solution ampule Ergometrine 200 microgram/mL solution for injection
Ergot compound allergy Allergy to ergot alkaloid (finding)
Eribulin mesylate 0.5mg/mL conventional release solution for injection Product containing only eribulin in parenteral dose form (medicinal product form)
Eribulin mesylate 0.5mg/mL solution for intravenous infusion Product containing only eribulin in parenteral dose form (medicinal product form)
Erroneous concept Erroneous component (foundation metadata concept)
Ertapenem 1g powder for infusion solution vial Ertapenem (as ertapenem sodium) 1 g powder for solution for injection vial
Erwinia ananas Pantoea ananatis (organism)
Erwinia cacticida Pectobacterium cacticida (organism)
Erwinia cancerogena Enterobacter cancerogenus
Erwinia carnegieana Genus Dickeya (organism)
Erwinia carotovora Pectobacterium carotovorum (organism)
Erwinia carotovora ss. atroseptica Pectobacterium atrosepticum (organism)
Erwinia carotovora ss. betavasculorum Pectobacterium betavasculorum (organism)
Erwinia carotovora ss. carotovora Pectobacterium carotovorum subspecies carotovorum (organism)
Erwinia carotovora subsp odorifera Pectobacterium carotovorum subspecies odoriferum (organism)
Erwinia cartovora subsp cartobora Pectobacterium carotovorum subspecies carotovorum (organism)
Erwinia cartovora subsp wasabiae Pectobacterium wasabiae (organism)
Erwinia chrysanthemi Dickeya chrysanthemi (organism)
Erwinia cypripedii Pantoea cypripedii (organism)
Erwinia herbicola Pantoea agglomerans
Erwinia nigrifluens Brenneria nigrifluens (organism)
Erwinia paradisiaca Dickeya paradisiaca (organism)
Erwinia quercina Lonsdalea quercina (organism)
Erwinia rhapontici Pectobacterium rhapontici (organism)
Erwinia rubrifaciens Brenneria rubrifaciens (organism)
Erwinia salicis Brenneria salicis (organism)
Erwinia stewartii Pantoea stewartii subsp stewartii
Erwinia uredovora Pantoea ananatis (organism)
Erythema infectiosum virus Primate erythroparvovirus 1 (organism)
Erythema multiforme due to mycoplasma infection Erythema multiforme due to Mycoplasma pneumoniae infection (disorder)
Erythromycin 250mg e/c granules in capsule Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug)
Erythromycin 250mg gastro-resistant oral capsule Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug)
Erythromycin 250mg m/r capsule Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug)
Erythromycin ethylsuccinate 100 mg/2.5mL Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug)
Erythromycin ethylsuccinate 100mg/2.5mL oral suspension Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug)
Erythromycin ethylsuccinate 100mg/2.5mL suspension Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug)
Erythromycin ethylsuccinate 200mg/5mL Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug)
Erythromycin ethylsuccinate 200mg/5mL liquid Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug)
Erythromycin ethylsuccinate 200mg/5mL oral suspension Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug)
Erythromycin ethylsuccinate 200mg/5mL suspension Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug)
Erythromycin ethylsuccinate 400mg film Erythromycin (as erythromycin ethyl succinate) 400 mg oral tablet
Erythromycin ethylsuccinate 400mg/5 mL Product containing precisely erythromycin (as erythromycin ethylsuccinate) 80 milligram/1 milliliter conventional release oral suspension (clinical drug)
Erythromycin ethylsuccinate 400mg/5mL oral suspension Product containing precisely erythromycin (as erythromycin ethylsuccinate) 80 milligram/1 milliliter conventional release oral suspension (clinical drug)
Erythromycin ethylsuccinate 400mg/5mL powder Product containing precisely erythromycin (as erythromycin ethylsuccinate) 80 milligram/1 milliliter conventional release oral suspension (clinical drug)
Erythromycin ethylsuccinate 400mg/5mL suspension Product containing precisely erythromycin (as erythromycin ethylsuccinate) 80 milligram/1 milliliter conventional release oral suspension (clinical drug)
Erythromycin lactobionate 1g injection (pdr for recon) Product containing only erythromycin in parenteral dose form (medicinal product form)
Erythromycin lactobionate 1g powder for infusion solution vial Product containing only erythromycin in parenteral dose form (medicinal product form)
Erythromycin lactobionate 500mg Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Erythromycin lactobionate 500mg injection (pdr for recon) Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Erythromycin lactobionate 500mg powder for infusion solution vial Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Erythromycin lactobionate 500mg/mL injection Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Escherichia coli serotype O7:H157 Escherichia coli serotype O157:H7 (organism)

Start Previous Page 63 of 235 Next End


Reference Sets

Reference set descriptor

Back to Start